Portside Wealth Group, LLC Novartis Ag Transaction History
Portside Wealth Group, LLC
- $675 Billion
- Q2 2025
A detailed history of Portside Wealth Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Portside Wealth Group, LLC holds 5,185 shares of NVS stock, worth $680,997. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,185
Previous 4,622
12.18%
Holding current value
$680,997
Previous $515 Million
21.77%
% of portfolio
0.09%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,570Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$993 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$935 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...